Predictive Value Alteration of Laboratory Routine and Ferritin/Transferrin Ratio in Monitoring of COVID-19 Patients

被引:1
|
作者
Zali, Fatemeh [1 ]
Mardani, Rajab [2 ]
Farahmand, Mohammad [3 ]
Ahmadi, Nayebali [4 ]
Shahali, Maryam [5 ]
Salehi-Vaziri, Mostafa [6 ]
Doroud, Delaram [5 ,7 ]
Aghasadeghi, Mohammad R. [7 ,8 ]
Sadeghi, Seyed A. [7 ,8 ]
Mousavi-Nasab, Seyed D. [6 ,7 ]
机构
[1] Univ Tehran Med Sci, Fac Med, Dept Clin Biochem, Tehran, Iran
[2] Hamedan Univ Med Sci, Sch Med, Dept Clin Biochem, Hamadan, Hamadan, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Prote Res Ctr, Dept Med Lab Technol, Tehran, Iran
[5] Pasteur Inst Iran, Dept Res Dev, Prod & Res Complex, Tehran, Iran
[6] Pasteur Inst Iran, Dept Arboviruses & Viral Hemorrhag Fevers, Tehran, Iran
[7] Pasteur Inst Iran, Dept Viral Vaccines Res Ctr, Tehran, Iran
[8] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran
关键词
SARS-CoV-2; COVID-19; ferritin; transferrin ratio (FTR); NLR; laboratory biomarkers; SEVERITY;
D O I
10.7754/Clin.Lab.2022.211213
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Inflammatory processes activated by rapid viral replication of SARS-CoV-2 can play a key role in the pathogenesis of multiple organ damage and be responsible for the COVID-19 patients' dramatic outcomes and common abnormal laboratory findings. The aim of this study was to assess the correlation between various laboratory biomarkers, ferritin/transferrin ratio (FTR) and receiver operating characteristic (ROC) analysis in monitoring COVID-19 patients. Methods: This observational study was conducted in three groups: healthy participants, non COVID-19 patients with COVID-19-like clinical signs, and COVID-19 patients (severe and non-severe). Biochemical (CRP, ferritin, transferrin and albumin) and hematological (WBC, lymphocytes) parameters were assessed by automated methods. Moreover, FTR and NLR markers were calculated in the three groups mentioned. Statistical analyses were done using R (version 4.1.0). ROC curve was used to validate the predictive value of parameters. Results: The COVID-19 positive group had significantly higher NEU, CRP, ferritin, FTR values, while it's WBC, absolute counts of lymphocytes and albumin were significantly lower compared to the non-COVID-19 patients (p < 0.001). Serum ferritin and FTR level of the severe group was significantly higher than that of the non-severe group (p = 0.006 and (p = 0.011, respectively). The strongest correlation in all subjects showed between lymphocytopenia and increased NEU (r = -0.99, p < 0.001). The AUC values of WBC (0.95), lymphocytes ( 0.89), NEU (0.88), and NLR ( 0.88) were higher than CRP (0.64) or Ferritin (0.81). Conclusions: We recommend using FTR, WBC, and NLR changes as simple, useful, and inexpensive indicators in early detection of COVID-19 patients.
引用
收藏
页码:2040 / 2046
页数:7
相关论文
共 50 条
  • [31] Procalcitonin and transferrin as a survival markers of patients with COVID-19
    Chrostek, L.
    Gan, K.
    Kazberuk, M.
    Kralisz, M.
    Gruszewska, E.
    Panasiuk, A.
    Cylwik, B.
    CLINICA CHIMICA ACTA, 2024, 558 : 26 - 27
  • [32] Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
    Akinori Higaki
    Hideki Okayama
    Yoshito Homma
    Takahide Sano
    Takeshi Kitai
    Taishi Yonetsu
    Sho Torii
    Shun Kohsaka
    Shunsuke Kuroda
    Koichi Node
    Yuya Matsue
    Shingo Matsumoto
    Scientific Reports, 12
  • [33] Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
    Higaki, Akinori
    Okayama, Hideki
    Homma, Yoshito
    Sano, Takahide
    Kitai, Takeshi
    Yonetsu, Taishi
    Torii, Sho
    Kohsaka, Shun
    Kuroda, Shunsuke
    Node, Koichi
    Matsue, Yuya
    Matsumoto, Shingo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [34] Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19
    Xia, Wei
    Tan, Yafeng
    Hu, Shengmei
    Li, Chengbin
    Jiang, Tao
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [35] Routine laboratory testing to determine if a patient has COVID-19
    Stegeman, Inge
    Ochodo, Eleanor A.
    Guleid, Fatuma
    Holtman, Gea A.
    Yang, Bada
    Davenport, Clare
    Deeks, Jonathan J.
    Dinnes, Jacqueline
    Dittrich, Sabine
    Emperador, Devy
    Hooft, Lotty
    Spijker, Rene
    Takwoingi, Yemisi
    Van den Bruel, Ann
    Wang, Junfeng
    Langendam, Miranda
    Verbakel, Jan Y.
    Leeflang, Mariska Mg
    EMERGENCIAS, 2022, 34 (06): : 465 - 467
  • [36] Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19
    Xia, Wei
    Tan, Yafeng
    Hu, Shengmei
    Li, Chengbin
    Jiang, Tao
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [37] Predictive Value of Systemic Immune-Inflammation index and Neutrophil-to-Lymphocyte Ratio in Patients with Severe COVID-19
    Xia, Wei
    Tan, Yafeng
    Hu, Shengmei
    Li, Chengbin
    Jiang, Tao
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [38] Routine laboratory testing to determine if a patient has COVID-19
    Stegeman, Inge
    Ochodo, Eleanor A.
    Guleid, Fatuma
    Holtman, Gea A.
    Yang, Bada
    Davenport, Clare
    Deeks, Jonathan J.
    Dinnes, Jacqueline
    Dittrich, Sabine
    Emperador, Devy
    Hooft, Lotty
    Spijker, Rene
    Takwoingi, Yemisi
    Van den Bruel, Ann
    Wang, Junfeng
    Langendam, Miranda
    Verbakel, Jan Y.
    Leeflang, Mariska M. G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (11):
  • [39] The Value of Remote Monitoring for the COVID-19 Pandemic
    Watson, Andrew R.
    Wah, Robert
    Thamman, Ritu
    TELEMEDICINE AND E-HEALTH, 2020, 26 (09) : 1110 - 1112
  • [40] Diagnostic and predictive value of hematological parameters of COVID-19 patients: a retrospective study
    Kiriwenno, Estie Ludi
    Indrasari, Yulia Nadar
    BALI MEDICAL JOURNAL, 2023, 12 (02) : 1446 - 1450